Apoptosome and inflammasome: Conserved machineries for caspase activation

National Science Review

Volumn 1, Issue 1, 2014, Pages 101-118

  Chai, Jijie ^a   Shi, Yigong ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

Apoptosis; Apoptosome; Caspase activation; Inflammasome; Inflammation

Indexed keywords

EID: 84901254102     PISSN: 20955138     EISSN: 2053714X     Source Type: Journal    
DOI: 10.1093/nsr/nwt025     Document Type: Review

References (133)

1. Danial, NN and Korsmeyer, SJ. Cell death: critical control points. Cell 2004; 116: 205-19.
2. Horvitz, HR. Worms, life, and death (nobel lecture). Chembiochem 2003; 4: 697-711.
3. Steller, H. Regulation of apoptosis in Drosophila. Cell Death Differ 2008; 15: 1132-8.
4. Thornberry, NA and Lazebnik, Y. Caspases: enemies within. Science 1998; 281: 1312-6.
5. Shi, Y. Mechanisms of caspase inhibition and activation during apoptosis. Mol Cell 2002; 9: 459-70.
6. Degterev, A, Boyce, M and Yuan, J. A decade of caspases. Oncogene 2003; 22: 8543-67.
7. Riedl, SJ and Shi, Y. Molecular mechanisms of caspase regulation during apoptosis. Nature Review Mol Cell Biol 2004; 5: 897-907.
8. Thornberry, NA, Bull, HG and Calaycay, JR et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992; 356: 76874.
9. Cerreti, DP, Kozlosky, CJ and Mosley, B et al. Molecular cloning of the interleukin-1 beta converting enzyme. Science 1992; 256: 97-100.
10. Fink, SL and Cookson, BT. Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell Microbiol 2005; 8: 1812-25.
11. Fink, SL and Cookson, BT. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun 2005; 73: 1907-16.
12. Martinon, F and Tschopp, J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 2007; 14: 10-22.
13. Yuan, J, Shaham, S and Ledoux, S et al. The C. elegans cell death gene Ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 1993; 75: 641-52.
14. Xue, D, Shaham, S and Horvitz, HR. The Caenorhabditis elegans cell-death protein CED-3 is a cysteine protease with substrate specificities similar to those of the human CPP32 protease. Genes Dev 1996; 10: 1073-83.
15. Denning, DP, Hatch, V and Horvitz, HR. Both the caspase CSP-1 and a caspase-independent pathway promote programmed cell death in parallel to the canonical pathway for apoptosis in Caenorhabditis elegans. PLoS Genet 2013; 9: e1003341.
16. Salvesen, GS and Dixit, VM. Caspase activation: the inducedproximity model. Proc Natl Acad Sci USA 1999; 96: 10964-7.
17. Chai, J, Wu, Q and Shiozaki, E et al. Crystal structure of a procaspase-7 zymogen: mechanisms of activation and substrate binding. Cell 2001; 107: 399-407.
18. Riedl, SJ, Fuentes-Prior, P and Renatus, M et al. Structural basis for the activation of human procaspase-7. Proc Natl Acad Sci USA 2001; 98: 14790-5.
19. Thomsen, ND, Koerber, JT and Wells, JA. Structural snapshots reveal distinct mechanisms of procaspase-3 and-7 activation. Proc Natl Acad Sci USA 2013; 110: 8477-82.
20. Zou, H, Li, Y and Liu, X et al. An APAF-1-cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 1999; 274: 11549-56.
21. Kischkel, FC, Hellbardt, S and Behrmann, I et al. Cytotoxicitydependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 1995; 14: 5579-88.
22. Srinivasula, SM, Poyet, JL and Razmara, M et al. The PYRINCARD protein ASC is an activating adaptor for caspase-1. J Biol Chem 2002; 277: 21119-22.
23. Martinon, F, Burns, K and Tschopp, J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002; 10: 417-26.
24. Stennicke, HR, Deveraux, QL and Humke, EW et al. Caspase-9 can be activated without proteolytic processing. J Biol Chem 1999; 274: 8359-62.
25. Srinivasula, SM, Saleh, A and Hedge, R et al. A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO mediates opposing effects on caspase activity and apoptosis. Nature 2001; 409: 112-6.
26. Hu, Q, Wu, D and Chen, W et al. Proteolytic processing of the caspase-9 zymogen is required for apoptosome-mediated activation of caspase-9. J Biol Chem 2013; 288: 15142-7.
27. Acehan, D, Jiang, X and Morgan, DG et al. Three-dimensional structure of the apoptosome: Implications for assembly, procaspase-9 binding and activation. Mol Cell 2002; 9: 423-32.
28. Saleh, A, Srinivasula, SM and Acharya, S et al. Cytochrome c and dATPmediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation. J Biol Chem 1999; 274: 17941-5.
29. Hu, Y, Benedict, MA and Ding, L et al. Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis. EMBO J 1999; 18: 3586-95.
30. Rodriguez, J and Lazebnik, Y. Caspase-9 and Apaf-1 form an active holoenzyme. Genes Dev 1999; 13: 3179-84.
31. Cain, K, Brown, DG and Langlais, C et al. Caspase activation involves the formation of the aposome, a large (~700 kDa) caspase-activating complex. J Biol Chem 1999; 274: 22686-92.
32. Rodriguez, A, Oliver, H and Zou, H et al. Dark is a Drosophila homologue of Apaf-1/CED-4 and functions in an evolutionarily conserved death pathway. Nat Cell Biol 1999; 1: 272-9.
33. Zhou, L, Song, Z and Tittel, J et al. HAC-1, a Drosophila homolog of Apaf-1 and CED-4 functions in developmental and radiation-induced apoptosis. Mol Cell 1999; 4: 745-55.
34. Kanuka, H, Sawamoto, K and Inohara, N et al. Control of the cell death pathway by Dapaf-1, a Drosophila Apaf-1/CED-4-related caspase activator. Mol Cell 1999; 4: 757-69.
35. Yuan, J and Horvitz, HR. The Caenorhabditis elegans cell death gene ced-4 encodes a novel protein and is expressed during the period of extensive programmed cell death. Development 1992; 116: 309-20.
36. Irmler, M, Hofmann, K and Vaux, D et al. Direct physical interaction between the Caenorhabditis elegans 'death proteins' CED-3 and CED-4. FEBS Lett 1997; 406: 189-90.
37. Seshagiri, S and Miller, LK. Caenorhabditis elegans CED-4 stimulates CED-3 processing and CED-3-induced apoptosis. Curr Biol 1997; 7: 455-60.
38. Chinnaiyan, AM, O'Rourke, K and Lane, BR et al. Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science 1997; 275: 1122-6.
39. Wu, D, Wallen, HD and Nunez, G. Interaction and regulation of subcellular localization of CED-4 by CED-9. Science 1997; 275: 1126-9.
40. Yang, X, Chang, HY and Baltimore, D. Essential role of CED-4 oligomerization in CED-3 activation and apoptosis. Science 1998; 281: 1355-7.
41. Lamkanfi, M and Dixit, VM. Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol 2012; 28: 137-61.
42. von Moltke, J, Ayres, JS and Kofoed, EM. Chavarría-Smith J, RE V, recognition of bacteria by inflammasomes. Annu Rev Immunol 2013; 31: 73-106.
43. Leipe, DD, Koonin, EV and Aravind, L. STAND, a class of P-loop NTPases including animal and plant regulators of programmed cell death: multiple, complex domain architectures, unusual phyletic patterns, and evolution by horizontal gene transfer. J Mol Biol 2004; 343: 1-28.
44. Tinel, A and Tschopp, J. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 2004; 304: 843-6.
45. Yuan, S and Akey, CW. Apoptosome structure, assembly, and procaspase activation. Structure 2013; 21: 501-15.
46. Bratton, SB and Salvesen, GS. Regulation of the Apaf-1-caspase-9 apoptosome. J Cell Sci 2010; 123: 3209-14.
47. Shi, Y. Apoptosome assembly. Methods Enzymol 2008; 442: 141-56.
48. Liu, X, Kim, CN and Yang, J et al. Induction of apoptosis program in cell-free extracts: requirement for dATP and cytochrome c. Cell 1996; 86: 147-57.
49. Zou, H, Henzel, WJ and Liu, X et al. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997; 90: 405-13.
50. Li, P, Nijhawan, D and Budihardjo, I et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91: 479-89.
51. Qin, H, Srinivasula, SM and Wu, G et al. Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1. Nature 1999; 399: 547-55.
52. Benedict, MA, Hu, Y and Inohara, N et al. Expression and functional analysis of Apaf-1 isoforms. Extra Wd-40 repeat is required for cytochrome c binding and regulated activation of procaspase-9. J Biol Chem 2000; 275: 8461-8.
53. Riedl, SJ, Li, W and Chao, Y. Schwarzenbacher R, Shi Y, structure of the apoptotic protease activating factor 1 bound to ADP. Nature 2005; 434: 926-33.
54. Reubold, TF, Wohlgemuth, S and Eschenburg, S. Crystal structure of fulllength Apaf-1: how the death signal is relayed in the mitochondrial pathway of apoptosis. Structure 2011; 19: 1074-83.
55. Yuan, S, Yu, X and Topf, M et al. Structure of an apoptosome-procaspase-9 CARD complex. Structure 2010; 18: 571-83.
56. Yu, X, Acehan, D and Menetret, JF et al. A structure of the human apoptosome at 12.8 A resolution provides insights into this cell death platform. Structure 2005; 13: 1725-35.
57. Yuan, S, Yu, X and Asara, JM et al. The holo-apoptosome: activation of procaspase-9 and interactions with caspase-3. Structure 2011; 19: 1084-96.
58. Bao, Q, Lu, W and Rabinowitz, JD et al. Calcium blocks formation of apoptosome by preventing nucleotide exchange in Apaf-1. Mol Cell 2007; 25: 181-92.
59. Reubold, TF, Wohlgemuth, S and Eschenburg, S. A new model for the transition of APAF-1 from inactive monomer to caspase-activating apoptosome. J Biol Chem 2009; 284: 32717-24.
60. Kim, HE, Du, F and Fang, M et al. Formation of apoptosome is initiated by cytochrome c-induced dATP hydrolysis and subsequent nucleotide exchange on Apaf-1. Proc Natl Acad Sci USA 2005; 102: 17545-50.
61. Jiang, X, Kim, HE and Shu, H et al. Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science 2003; 299: 223-6.
62. Cain, K, Langlais, C and Sun, XM et al. Physiological concentrations of K+ inhibit cytochrome c-dependent formation of the apoptosome. J Biol Chem 2001; 276: 41985-90.
63. Karki, P, Seong, C and Kim, JE et al. Intracellular K(+) inhibits apoptosis by suppressing the Apaf-1 apoptosome formation and subsequent downstream pathways but not cytochrome c release. Cell Death Differ 2007; 14: 2068-75.
64. Chandra, D, Bratton, SB and Person, MD et al. Intracellular nucleotides act as critical prosurvival factors by binding to cytochrome c and inhibiting apoptosome. Cell 2006; 125: 1333-46.
65. Chereau, D, Zou, H and Spada, AP et al. A nucleotide binding site in caspase-9 regulates apoptosome activation. Biochemistry 2005; 44: 4971-6.
66. Boatright, KM and Salvesen, GS. Mechanisms of caspase activation. Curr Opin Cell Biol 2003; 15: 725-31.
67. Renatus, M, Stennicke, HR and Scott, FL et al. Dimer formation drives the activation of the cell death protease caspase 9. Proc Natl Acad Sci USA 2001; 98: 14250-5.
68. Pop, C, Timmer, J and Sperandio, S et al. The apoptosome activates caspase-9 by dimerization. Mol Cell 2006; 22: 269-75.
69. Walker, NP, Talanian, RV and Brady, KD et al. Crystal structure of the cysteine protease interleukin-1b-converting enzyme: a (p20/p10)2 homodimer. Cell 1994; 78: 343-52.
70. Wilson, KP, Black, J-A and Thomson, JA et al. Structure and mechanism of interleukin-1b converting enzyme. Nature 1994; 370: 270-5.
71. Rotonda, J, Nicholson, DW and Fazil, KM et al. The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis. Nat Struct Biol 1996; 3: 619-25.
72. Yin, Q, Park, HH and Chung, JY et al. Caspase-9 holoenzyme is a specific and optimal procaspase-3 processing machine. Mol Cell 2006; 22: 259-68.
73. Shi, Y. Caspase activation: revisiting the induced proximity model. Cell 2004; 117: 855-8.
74. Chao, Y, Shiozaki, EN and Srinivasula, SM et al. Engineering a dimeric caspase-9: a re-evaluation of the induced proximity model for caspase activation. PLoS Biol 2005; 3: e183.
75. Dorstyn, L, Colussi, PA and Quinn, LM et al. DRONC, an ecdysone-inducible Drosophila caspase. Proc Natl Acad Sci USA 1999; 96: 4307-12.
76. Chew, SK, Akdemir, F and Chen, P et al. The apical caspase Dronc governs programmed and unprogrammed cell death in Drosophila. Dev Cell 2004; 7: 897-907.
77. Daish, TJ, Mills, K and Kumar, S. Drosophila caspase DRONC is required for specific developmental cell death pathways and stress-induced apoptosis. Dev Cell 2004; 7: 909-15.
78. Muro, I, Monser, K and Clem, RJ. Mechanism of Dronc activation in Drosophila cells. J Cell Sci 2004; 117: 5035-41.
79. Yu, X, Wang, L and Acehan, D et al. Three-dimensional structure of a double apoptosome formed by the Drosophila Apaf-1 related killer. J Mol Biol 2006; 355: 577-89.
80. Diemand, AV and Lupas, AN. Modeling AAA + ring complexes from monomeric structures. J Struct Biol 2006; 156(1): 230-43.
81. Yuan, S, Yu, X and Topf, M et al. Structure of the Drosophila apoptosome at 6.9 °A resolution. Structure 2011; 19: 128-40.
82. Dorstyn, L and Kumar, S. A biochemical analysis of the activation of the Drosophila caspase DRONC. Cell Death Differ 2008; 15: 461-70.
83. Snipas, SJ, Drag, M and Stennicke, HR et al. Activation mechanism and substrate specificity of the Drosophila initiator caspase DRONC. Cell Death Differ 2008; 15: 938-45.
84. Yan, N, Huh, JR and Schirf, V et al. Structure and activation mechanism of the Drosophila initiator caspase Dronc. J Biol Chem 2006; 281: 8667-74.
85. Horvitz, HR. Genetic control of programmed cell death in the nematode Caenorhabditis elegans. Cancer Res 1999; 59: 1701-6.
86. Hengartner, MO and Horvitz, HR. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 1994; 76: 665-76.
87. Chen, F, Hersh, BM and Conradt, B et al. Translocation of C. elegans CED-4 to nuclear membranes during programmed cell death. Science 2000; 287: 1485-9.
88. James, C, Gschmeissner, S and Fraser, A et al. CED-4 induces chromatin condensation in Schizosaccharomyces pombe and is inhibited by direct physical association with CED-9. Curr Biol 1997; 7: 246-52.
89. Spector, MS, Desnoyers, S and Hoeppner, DJ et al. Interaction between the C. elegans cell-death regulators CED-9 and CED-4. Nature 1997; 385: 653-6.
90. Conradt, B and Horvitz, HR. The C. elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9. Cell 1998; 93: 519-29.
91. del Peso, L, Gonzalez, VM and Nunez, G. Caenorhabditis elegans EGL-1 disrupts the interaction of CED-9 with CED-4 and promotes CED-3 activation. J Biol Chem 1998; 273: 33495-500.
92. del Peso, L, Gonzalez, VM and Inohara, N et al. Disruption of the CED-9.CED-4 complex by EGL-1 is a critical step for programmed cell death in Caenorhabditis elegans. J Biol Chem 2000; 275: 27205-11.
93. Parrish, J, Metters, H and Chen, L et al. Demonstration of the in vivo interaction of key cell death regulators by structure-based design of second-site suppressors. Proc Natl Acad Sci USA 2000; 97: 11916-21.
94. Yan, N, Chai, J and Lee, ES et al. Structure of the CED-4-CED-9 complex provides insights into programmed cell death in Caenorhabditis elegans. Nature 2005; 437: 831-7.
95. Yan, N, Xu, Y and Shi, Y. 2:1 Stoichiometry of the CED-4-CED-9 Complex and the tetrameric CED-4: insights into the regulation of CED-3 activation. Cell Cycle 2006; 5: 31-4.
96. Yan, N, Gu, L and Kokel, D et al. Structural, biochemical, functional analyses of CED-9 recognition by the proapoptotic proteins EGL-1 and CED-4. Mol Cell 2004; 15: 999-1006.
97. Qi, S, Pang, Y and Hu, Q et al. Crystal structure of the Caenorhabditis elegans apoptosome reveals an octameric assembly of CED-4. Cell 2010; 141: 446-57.
98. Huang, W, Jiang, T and Choi, W et al. Mechanistic insights into CED-4-mediated activation of CED-3. Genes Dev 2013. In press.
99. Hu, Z, Yan, C and Liu, P et al. Crystal structure of NLRC4 reveals its autoinhibition mechanism. Science 2013; 341: 172-5.
100. Poyet, JL, Srinivasula, SM and Tnani, M et al. Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1. J Biol Chem 2001; 276: 28309-13.
101. Kofoed, EM and Vance, RE. Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature 2011; 477: 592-5.
102. Danot, O, Marquenet, E and Vidal-Ingigliardi, D et al. Wheel of life, wheel of death: a mechanistic insight into signaling by STAND proteins. Structure 2009; 17: 172-82.
103. Erzberger, JP and Berger, JM. Evolutionary relationships and structural mechanisms of AAA+proteins. Annu Rev Biophys Biomol Struct 2006; 35: 93-114.
104. Rossman, KL, Der, CJ and Sondek, J. GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 2005; 6: 167-80.
105. Bendahmane, A, Farnham, G and Moffett, P et al. Constitutive gain-offunction mutants in a nucleotide binding site-leucine rich repeat protein encoded at the Rx locus of potato. Plant J 2002; 32: 195-204.
106. de la Fuente van Bentem, S, Vossen, JH and de Vries, KJ et al. Heat shock protein 90 and its co-chaperone protein phosphatase 5 interact with distinct regions of the tomato I-2 disease resistance protein. Plant J 2005; 43: 284-98.
107. Howles, P, Lawrence, G and Finnegan, J et al. Autoactive alleles of the flax L6 rust resistance gene induce non-race-specific rust resistance associated with the hypersensitive response. Mol Plant Microbe In 2005; 18: 570-82.
108. Gabriels, SH, Vossen, JH and Ekengren, SK et al. An NB-LRR protein required for HR signallingmediated by both extra-and intracellular resistance proteins. Plant J 2007; 50: 14-28.
109. Faustin, B, Lartigue, L and Bruey, JM et al. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol Cell 2007; 25: 713-24.
110. Halff, EF, Diebolder, CA and Versteeg, M et al. Formation and structure of a NAIP5-NLRC4 inflammasome induced by direct interactions with conserved N-and C-terminal regions of flagellin. J Biol Chem 2012; 287: 38460-72.
111. Cassel, SL, Joly, S and Sutterwala, FS. The NLRP3 inflammasome: a sensor of immune danger signals. Semin Immunol 2009; 21: 194-1981.
112. Bryant, C and Fitzgerald, KA. Molecular mechanisms involved in inflammasome activation. Trends Cell Biol 2009; 19: 455-64.
113. Tschopp, J and Schroder, K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 2010; 10: 210-5.
114. Wen, H, Miao, EA and Ting, JP. Mechanisms of NOD-like receptor-associated inflammasome activation. Immunity 2013; 39: 432-41.
115. Nakahira, K, Haspel, JA and Rathinam, VA et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 2011; 12: 222-30.
116. Zhou, R, Yazdi, AS and Menu, P et al. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011; 469: 221-5.
117. Subramanian, N, Natarajan, K and Clatworthy, MR et al. The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation. Cell 2013; 153: 348-61.
118. Iyer, SS, He, Q and Janczy, JR et al. Mitochondrial cardiolipin is required for nlrp3 inflammasome activation. Immunity 2013; 39: 311-23.
119. Strowig, T, Henao-Mejia, J and Elinav, E et al. Inflammasomes in health and disease. Nature 2012; 481: 278-86.
120. Davis, BK, Wen, H and Ting, JP. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 2011; 29: 707-35.
121. Hoffman, HM, Mueller, JL and Broide, DH et al. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001; 29: 301-5.
122. Feldmann, J, Prieur, AM and Quartier, P et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 2002; 71: 198-203.
123. Aksentijevich, I, Nowak, M and Mallah, M et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum 2002; 46: 3340-8.
124. Masters, SL, Simon, A and Aksentijevich, I et al. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). Annu Rev Immunol 2009; 27: 621-68.
125. Stojanov, S and Kastner, DL. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 2005; 17: 586-99.
126. Hull, KM, Shoham, N and Chae, JJ et al. The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations. Curr Opin Rheumatol 2003; 15: 61-9.
127. Duncan, JA, Bergstralh, DT and Wang, Y et al. Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling. Proc Natl Acad Sci USA 2007; 104: 8041-6.
128. Dowds, TA, Masumoto, J and Zhu, L et al. Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC. J Biol Chem 2004; 279: 21924-8.
129. Meng, G, Zhang, F and Fuss, I et al. A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity 2009; 30: 860-74.
130. Neven, B, Callebaut, I and Prieur, AM et al. Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood 2004; 103: 2809-15.
131. Tameling, WI, Vossen, JH and Albrecht, M et al. Mutations in the NB-ARC domain of I-2 that impair ATP hydrolysis cause autoactivation. Plant Physiol 2006; 140: 1233-45.
132. Hiller, S, Kohl, A and Fiorito, F et al. NMR structure of the apoptosis-and inflammation-related NALP1 pyrin domain. Structure 2003; 11: 1199-1205.
133. DeLano, WL. The Py MOL molecular graphics system. http://www.pymol.org, 2002.